| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/12/2007 | WO2007039936A1 Compositions for application to mucosa |
| 04/12/2007 | WO2007039322A1 Use of vitamin d3 compounds for the treatment of uveitis |
| 04/12/2007 | WO2007039201A2 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
| 04/12/2007 | WO2007038949A1 Pharmaceutical compositions for the treatment of inner ear disorders |
| 04/12/2007 | WO2007011843A3 Prevention and treatment of ophthalmic complications of diabetes |
| 04/12/2007 | WO2007011720A3 Cyclopentane n-lower alkyl heptenamide-5-cis-2- (3alapha- hydroxy-5-phenylpentyl) -3, ?5-dihydroxy, [1alpha, 2beta, 3alpha, 5alpha] compounds as agents for lowering intraocular pressure |
| 04/12/2007 | WO2007008942A3 Phenylamino-acetic acid [1-(pyridin-4-yl)-methylidene]-hydrazide derivatives and related compounds as modulators of g protein-coupled receptor kinases for the treatment of eye diseases |
| 04/12/2007 | WO2006129867A3 ENHANCED EXPRESSION OF LACTOFERRIN mRNA BY LACRITIN |
| 04/12/2007 | WO2006059357A3 Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/ or reversing ocular diseases related with ocular neovascularization |
| 04/12/2007 | US20070082041 Topical delivery of codrugs |
| 04/12/2007 | CA2624141A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | CA2624111A1 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
| 04/11/2007 | EP1772514A2 Manipulation of tissue or organ type using the notch pathway |
| 04/11/2007 | EP1771181A2 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 04/11/2007 | EP1771170A2 Ophthalmic compositions for treating ocular hypertension |
| 04/11/2007 | EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives |
| 04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 04/11/2007 | CN1946384A Statins for the treatment of ocular hypertension and glaucoma |
| 04/11/2007 | CN1944448A Puerarin derivative and its medicinal use |
| 04/11/2007 | CN1944433A 3-ene-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid amino acid amide, its synthetic method and light power therapeutic medicine |
| 04/11/2007 | CN1944432A 3-(1-alkoxy ethyl)-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid, its synthetic method and light power therapeutic medicine |
| 04/11/2007 | CN1943693A A Chinese traditional medicinal preparation for eye health and relieving visual fatigue |
| 04/11/2007 | CN1943668A A kind of medicine for treating acute catarrhal and epidemic conjunctivitis and its preparing method |
| 04/11/2007 | CN1943650A Rose liquid and its eye drops |
| 04/11/2007 | CN1943636A A health product for relieving eye tiredness |
| 04/11/2007 | CN1943630A Eye medicine for preventing and treating conjunctivitis and keratitis and its preparing method |
| 04/11/2007 | CN1943599A Eye medicine for treating and preventing and curing cataract and its preparing method |
| 04/11/2007 | CN1943598A Eye medicine for preventing and curing shortsightedness and relieving sight fatigue and its preparing method |
| 04/11/2007 | CN1943597A Formula for preparing eye gel |
| 04/11/2007 | CN1943596A Medicine for eye for preventing and curing conjunctivitis and keratitis and its preparing method |
| 04/11/2007 | CN1943590A Artificial tears for treating xerophthalmia |
| 04/11/2007 | CN1943577A Use of (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 04/11/2007 | CN1309833C Angiostatin and its use for preparing medicament |
| 04/11/2007 | CN1309813C Oil or fat composition |
| 04/11/2007 | CN1309710C Pyrimidine derivitive |
| 04/11/2007 | CN1309704C Anthranyl amides and their use as medicaments |
| 04/11/2007 | CN1309703C Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 04/11/2007 | CN1309419C A Blocking monoclonal antibody to VLA-1 and its use |
| 04/11/2007 | CN1309392C Hyaluronic acid mediated adenoviral transduction |
| 04/11/2007 | CN1309380C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 04/10/2007 | US7202278 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; for treatment of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
| 04/10/2007 | US7202274 Cyclic hemiacetal derivative and use thereof |
| 04/10/2007 | US7202273 Prevention of menopausal syndrome |
| 04/10/2007 | US7202268 1-Substituted with an alkylthioalkyl-, alkylsulfonylalkyl- or alkylaminosulfonylalkyl- group, e.g., 7-chloro-2-methyl-1-{3-[(methylsulfonyl)amino]-propyl}-N-[(1S)-endo-(1,3,3-trimethylbicyclo-[2.2.1]hept-2-yl)-1H-indole-3-carboxamide; cannabinoid CB2 receptor agonists |
| 04/10/2007 | US7202242 Substituted 1 and 2-naphthol Mannich bases |
| 04/10/2007 | US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity |
| 04/10/2007 | US7202067 Carotene synthase gene and uses therefor |
| 04/10/2007 | US7202066 Synergistic healing the wounds |
| 04/10/2007 | CA2407100C 1-aroyl-piperidinyl benzamidines |
| 04/10/2007 | CA2403869C Method for treating dry eye |
| 04/10/2007 | CA2270469C Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| 04/10/2007 | CA2189424C Non-steroidal anti-inflammatory ophthalmic suspensions |
| 04/10/2007 | CA2162306C Use of dl-(+/-)-.alpha.-lipoic acid, d-(+)-.alpha.-lipoic acid, .alpha. lipoic acid in reduced or oxidized form or salts for treating circulatory disorders |
| 04/05/2007 | WO2007038549A1 Treatment of inflammation and vascular abnormalities of the eye |
| 04/05/2007 | WO2007038372A1 Phenylethylamine analogs and their use for treating glaucoma |
| 04/05/2007 | WO2007038092A1 Combination methods for preserving visual acuity |
| 04/05/2007 | WO2007037554A1 Adsorbent for advanced glycation endproducts |
| 04/05/2007 | WO2007037245A1 Polypeptide having anti-angiogenic activity |
| 04/05/2007 | WO2007037188A1 Pharmaceutical for prevention and treatment of ophthalmic disease induced by increase in vasopermeability |
| 04/05/2007 | WO2007002670A3 Method of lowering intraocular pressure |
| 04/05/2007 | WO2003070751A3 Partial peptide mimetics and methods |
| 04/05/2007 | US20070078183 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 04/05/2007 | DE60124600T2 Zusammensetzungen und Verfahren zur Behandlung von Zuständen, die auf Östrogen ansprechen Compositions and methods for treating conditions responsive to estrogen |
| 04/05/2007 | DE102005046769A1 Ophthalmic composition, useful to treat eye diseases e.g. herpes simplex virus-epithelial keratitis, comprises brivudine, auxiliary materials and film former such as polyvinyl pyrrolidone, polyvinyl alcohol or polyacrylate |
| 04/05/2007 | CA2850858A1 Compositions and methods for the intraocular transport of therapeutic agents |
| 04/05/2007 | CA2622475A1 Treatment of inflammation and vascular abnormalities of the eye |
| 04/04/2007 | EP1768674A1 Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents |
| 04/04/2007 | EP1768657A1 Methods and compositions for treating ophthalmic conditions with retinyl derivates |
| 04/04/2007 | EP1768656A2 Treatment for ocular disease |
| 04/04/2007 | EP1551793A4 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 04/04/2007 | EP1536797B1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough |
| 04/04/2007 | EP1259595B1 Integrin antagonists |
| 04/04/2007 | EP1098642B1 Diamino-propanol-compounds for treating ischemia |
| 04/04/2007 | CN1942588A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/04/2007 | CN1942183A Isosorbide-containing jelly preparation |
| 04/04/2007 | CN1939915A 喹啉衍生物 Quinoline derivatives |
| 04/04/2007 | CN1939541A Immunostimulatory nucleic acids |
| 04/04/2007 | CN1939534A Externally-applied preparation containing human growth incretion or human granular leukocyte macrophage stimulus factor for treating injury ulceration |
| 04/04/2007 | CN1939506A Vision-improving preparation with depressor, blood-sugar and blood-fat lowering functions and its making method |
| 04/04/2007 | CN1939456A Chinese medicine eye drops and its making method |
| 04/04/2007 | CN1939357A Preparation of Ginkgo Damo injection |
| 04/04/2007 | CN1939340A 脂质体制剂 Liposomal formulations |
| 04/04/2007 | CN1939278A Methods for providing oxidatively stable ophthalmic compositions |
| 04/04/2007 | CN1939277A Methods for stabilizing ophthalmic compositions |
| 04/04/2007 | CN1308347C Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 04/04/2007 | CN1308320C Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 04/04/2007 | CN1308310C Nitrogenous aromatic ring compounds |
| 04/04/2007 | CN1307998C Novel method and compositions for local treatment of Meniere's disease, tinnitus and hearing loss |
| 04/04/2007 | CN1307995C Gatifloxacin eye drop and its preparing method |
| 04/04/2007 | CN1307992C Eye drops containing tetrazole derivative |
| 04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/03/2007 | US7199147 Rho kinase inhibitors |
| 04/03/2007 | US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists |
| 04/03/2007 | US7199130 Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists |
| 04/03/2007 | US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators |
| 04/03/2007 | US7199122 Administering 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione and/or metabolite thereof; treating neoplastic diseases, atherosclerosis, restenosis, rheumatoid arthritis, Crohn's disease, diabetic retinopathy, psoriasis, and endometriosis |
| 04/03/2007 | CA2419573C Method of increasing testosterone and related steroid concentrations in women |
| 04/03/2007 | CA2400945C Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 04/03/2007 | CA2294581C Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 04/03/2007 | CA2177578C Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors |